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 Abbreviations 
 
 
BMP15: bone morphogenetic protein-15  
cAMP: cyclic adenosine monophosphate 
ED: early diakinesis 
FC: filamentous chromatin stage 
FO: fully grown oocytes (120–130 µm in diameter) 
FSH: follicle stimulating hormone 
GCs: granulosa cell complexes 
GDF9: growth differentiation factor-9 
GO: growing oocytes (105–115 µm in diameter) 
GV: germinal vesicle I-IV stage 
HEPES-199: HEPES-buffered medium 199 
IBMX: 3-isobutyl-1-methylxanthine 
LD: late diakinesis 
LH: luteinizing hormone 
LY: lucifer yellow  
MI: metaphase I 
MII: metaphase II 
OGCs: oocyte-granulosa cell complexes 
OXCs: oocytectomized complexes 
PBS: phosphate-buffered saline 
PDE: phosphodiesterase 
PDE3: phosphodiesterase 3 
PDE4: phosphodiesterase 4 
PVA: polyvinyl alcohol 
SC: stringy chromatin stage 
TGF-β: transforming growth factor β 
 
 
1 
 
CHAPTER I 
General introduction 
 
Oogenesis is a series of processes of formation, growth and maturation of oocytes.  
Mammalian oogenesis starts at the embryonic period and primordial germ cells are the primary cells 
in oogenesis. After migration to the embryonic gonads, primordial germ cells become oogonia and 
they proliferate by mitosis. The oogonia subsequently enter meiosis I, then they are called oocytes, 
and become arrested at the diplotene stage of meiosis I (Pepling and Spradling, 1998). The oocytes 
become enclosed by a single layer of flattened pre-granulosa cells to form primordial follicles (Mayo 
et al., 2007) (Fig. 1). When oocytes start to grow, surrounding pre-granulosa cells become cubic 
granulosa cells to form primary follicles (Mhawi et al., 1991). The granulosa cells proliferate and 
form multilayered structure, and theca cell layers further surround the structure. Follicles at this stage 
are called secondary follicles. Later, an antral cavity is formed inside the follicles and they become 
antral follicles. At this stage, granulosa cells differentiate to cumulus granulosa cells which enclose 
the oocytes, and mural granulosa cells which form the inner layer of the follicle wall (Wigglesworth 
et al., 2015). In the meanwhile, the oocytes increase in size and acquire meiotic competence. After 
luteinizing hormone (LH) surge, oocytes resume meiosis to mature to metaphase II (MII) and finally 
they are ovulated. 
To utilize the non-growing and growing oocytes in the ovary, many attempts have been taken 
for in vitro growth culture of oocytes depending on their size (diameter) and stage of follicular 
development (Eppig et al., 1996; Miyano, 2005). The size at which oocytes complete their growth 
depends on species. Mouse oocytes grow from 15–20 µm to 70–80 µm, whereas porcine and bovine 
oocytes grow from 30 µm to 120–125 µm (Fair et al., 1995; Griffin et al., 2006). Mouse oocytes (50–
60 µm) from preantral follicles completed their growth and acquired full developmental competence 
in vitro and live young were produced after maturation and fertilization of the oocytes in vitro (Eppig 
and Schroeder, 1989). Eppig and O’Brine (1996) reported the complete mouse oocyte development 
oocytes (70–90 µm)   
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Figure 1  Oocyte growth and maturation in coordination with follicular development in the ovary. 
Follicular development starts from primordial follicles that have a single layer of flattened granulosa 
cells. Primary follicles are characterized by a change in the granulosa cells from flattened to cubic in 
shape. In secondary follicles, the granulosa cells proliferate to form multilayer, and later an antral 
cavity is formed inside the follicles and they become antral follicles. In antral follicles, granulosa cells 
differentiate to cumulus granulosa cells which enclose the oocytes, and mural granulosa cells which 
form the inner layer of the follicle wall. In the meanwhile, oocytes grow in the follicles, and finally 
matured oocytes are ovulated.   
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in vitro and produced offspring from oocytes (20 µm) in primordial follicles. In domestic species, 
Hirao et al. (1994) reported in vitro growth of pig growing oocytes (70–90 µm) from preantral 
follicles. In addition, baby calves have been produced after in vitro growth, maturation and 
fertilization of bovine growing oocytes (90–100 µm) from early antral follicles (Yamamoto et al., 
1999; Hirao et al., 2004). However, less emphasis has been given to growth culture of 100–120 µm 
oocytes from bovine early antral follicles. 
 Non-growing oocytes and growing oocytes have no ability to mature to MII. The acquisition 
of meiotic competence proceeds in an oocyte size-specific manner (Fair et al., 1995). First, oocytes 
acquire the capacity for resuming meiosis, and at the later stage of oocyte growth, they gain the ability 
to reach MII. Bovine oocytes in preantral follicles have no competence to resume meiosis. Oocytes 
acquire the competence to resume meiosis coincidentally with the formation of antrum structures in 
the follicles (Miyano and Manabe, 2007). Beyond this stage of oocyte growth, when oocytes are 
removed from follicles for culture, they resume meiosis spontaneously (Pincus and Enzmann, 1935). 
However, oocytes are arrested at prophase I throughout oocyte growth and never resume meiosis in 
the follicles before gonadotropic stimulation. Cyclic adenosine monophosphate (cAMP) plays an 
important role in the meiotic arrest of oocytes (Tsafriri and Dekel, 1994). Elevated cAMP 
concentrations in oocytes by cAMP analogs, pharmacological reagents that stimulate cAMP 
production, or by inhibition of cAMP degrading phosphodiesterases (PDEs), show inhibitory effects 
on meiotic resumption of fully grown oocytes, when oocyte-cumulus cell complexes are cultured in 
conditions allowing resumption of meiosis (Bilodeau-Goeseels, 2011; Conti, 2011).  However, the 
effects of PDE inhibitors on meiotic arrest in bovine oocytes are still controversial.  
 In the preliminary experiment, I found that some PDE inhibitors promoted formation of 
antrum structures in bovine oocyte-granulosa cell complexes (OGCs) during culture. Antrum in the 
antral follicle accumulates both hormonal and non-hormonal components to satisfy oocyte growth and 
to inhibit oocyte maturation, as well as to support the proliferation and steroidogenesis of granulosa 
cells (Edwards, 1974). The development of antrum in vitro has been reported by the culture of 
preantral follicles in the rat (Gore-Langton and Daniel, 1990), mouse (Nayudu and Osborn, 1992), 
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human (Roy and Treacy, 1993) and pig (Hirao et al., 1994). Culture studies of sheep (Cecconi et al., 
1999), porcine (Mao et al., 2002) and bovine (Itoh et al., 2002) preantral follicles show that follicle 
stimulating hormone (FSH) promotes antrum formation. Bovine OGCs developed antrum structures 
in the culture condition with high concentration of polyvinylpyrrolidone (Hirao et al., 2004). The 
mechanism underlying the antrum formation has not been established, although it was suggested that 
participation of oocytes is required for formation of antrum structures in pig oocyte-cumulus-mural 
granulosa cell complexes (Shen et al., 1998). 
During oocyte growth and follicular development, bidirectional communication between 
oocytes and granulosa cells is mediated by both gap junctions and paracrine factors (Eppig, 1991). In 
this intercellular communication, oocytes carry the conversation (Matzuk et al., 2002). The members 
of transforming growth factor β (TGF-β) superfamily, growth differentiation factor-9 (GDF9) and 
bone morphogenetic protein-15 (BMP15) have been shown to be oocyte-derived and to regulate 
female fertility (Elvin et al., 1999).  The histological analysis of GDF9 null mice revealed that the 
follicular development did not progress beyond the primary follicle stage (Dong et al., 1996). BMP15 
null mice showed defective follicular development, reduced ovulation rate and lack of attachment 
between oocytes and cumulus cells (Yan et al., 2001). GDF9 and BMP15 null mice also did not induce 
cumulus expansion during in vitro maturation of oocytes (Su et al., 2004). Although the several roles 
of these oocyte-derived factors in follicular regulation has been established, the role of those factors 
in follicular antrum formation has not been examined yet. 
In the present study, bovine OGCs containing growing oocytes (105–115 µm in diameter) 
were collected from early antral follicles (1.2–1.8 mm in diameter). These sized oocytes are able to 
resume meiosis, but lack the competence to mature to MII. To confer full maturation competence on 
the oocytes, culture systems which can support their growth and prevent meiotic resumption during 
culture are needed. Therefore, the effects of different PDE inhibitors on oocyte growth were examined 
during 5-day culture in Chapter II. Since inhibition of oocyte-specific PDE3 maintained meiotic arrest 
of oocytes and promoted antrum formation by OGCs, it was thought that PDE3 inhibitors might 
promote expression of some oocyte-derived factors. The expression of oocyte-derived GDF9 and 
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BMP15 were examined in oocytes after culture with PDE3 inhibitors in Chapter III. It was 
hypothesized that these oocyte-derived factors might promote the formation of antrum structures by 
OGCs. The effect of GDF9 and BMP15 on antrum formation by OGCs was examined in Chapter IV.   
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CHAPTER II 
Effect of PDE inhibitors on in vitro growth of bovine oocytes with partial meiotic 
competence 
 
Introduction 
 
In the ovary, oocyte growth is coordinated with follicular development, which occurs by 
morphological change and active proliferation of granulosa cells and formation of an antrum structure 
(Pedersen and Peters, 1968). The size and stage of follicles at which oocytes complete their growth 
are dependent on species. In mice, fully grown oocytes are obtained from early antral follicles 
(Sorensen and Wassarman, 1976), whereas porcine and bovine oocytes complete their growth in 
follicles at the middle antral stage (Motlik et al., 1984; Hirao et al., 1995; Fair et al., 1995). 
Acquisition of meiotic competence of oocytes depends on follicle size and oocyte diameter. Bovine 
oocytes with a diameter of <100 µm (from <1 mm follicles) are meiotically incompetent, whereas 
oocytes with a diameter of >120 µm (from ≥4 mm follicles) are meiotically competent to mature to 
MII (Fair et al., 1995).  
Many approaches have been taken to grow mammalian small oocytes in vitro (Eppig et al., 
1996; Miyano, 2005). For example, a variety of growth culture systems have been developed to utilize 
incompetent small oocytes (<100 µm) collected from bovine ovaries (Yamamoto et al., 1999; Miyano, 
2003; Hirao et al., 2004; Huang et al., 2013). Hirao and his colleagues developed a long-term growth 
culture system, in which bovine OGCs were cultured in medium supplemented with 4% (w/v) 
polyvinylpyrrolidone for 2 weeks (Hirao et al., 2004). This system supported the growth of bovine 
small oocytes (<100 µm), and OGCs formed antrum structures during the culture. In addition, some 
of the growth culture systems for bovine incompetent oocytes led to successful production of offspring 
(Yamamoto et al., 1999; Hirao et al., 2004; Huang et al., 2016). On the other hand, less emphasis has 
been given to the long-term growth culture of 100–120 µm oocytes. Bovine growing oocytes with 
diameters 
7 
 
diameters in this range have some unique features. They are characterized by ongoing RNA 
transcription (Luciano et al., 2011; Luciano et al., 2014; Labrecque et al., 2016), distinctive chromatin 
configuration (Hyttel, 2011; Luciano et al., 2014), specific epigenetic marks (O’Doherty et al., 2012; 
Luciano et al., 2014) and organelle distribution (Hyttel, 2011), all of which are different from those 
of fully grown oocytes. However, oocytes of this size are able to resume meiosis, although they are 
incompetent to mature to MII. Thus these oocytes are considered “partially meiotic-competent”, and 
their precocious resumption of meiosis during growth culture makes it difficult for them to grow to 
fully meiotic competent oocytes.  
The inhibition of meiotic resumption of fully grown oocytes using phosphodiesterase (PDE) 
inhibitors has been well studied in vitro (Gilchrist et al., 2016). It has been reported that PDE3 
inhibitors, not PDE4 inhibitors, prevent meiotic resumption of oocytes in several species (Conti, 
2011), although the effects of inhibitors are still controversial in bovine oocytes (Mayes and Sirard, 
2002; Thomas et al., 2002; Thomas et al., 2004a; Thomas et al., 2004b).  
Follicular oocytes are connected by gap junctions to surrounding cumulus cells which support 
oocyte growth and development (Buccione et al., 1990a; Lodde et al., 2007). In in vitro growth 
culture, the maintenance of gap junctions is essential for oocyte growth (Eppig, 1991). In addition to 
their effect on the meiotic arrest of oocytes, PDE inhibitors have also recently been reported to affect 
the gap junctional communication between oocytes and cumulus cells (Luciano et al., 2011). A broad-
spectrum PDE inhibitor (3-isobutyl-1-methylxanthine: IBMX) sustained gap junctional 
communication of bovine fully grown oocytes (Lodde et al., 2013), and cilostamide, a PDE3 inhibitor, 
prolonged the gap junction functionality of bovine growing oocytes (Luciano et al., 2011). So far, 
however, PDE inhibitors have not been applied for long-term growth culture of bovine growing 
oocytes.  
In this Chapter, bovine OGCs containing partially meiotic-competent oocytes (105‒115 µm) 
were cultured for growth for 5 days, and the effects of different PDE inhibitors on the growth, meiotic 
arrest, and acquisition of full-meiotic competence of these oocytes were examined. During the growth 
culture, I examined the effect of PDE inhibitors on the antrum formation by OGCs, and at the end of 
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the growth culture, the gap junctional communication between oocytes and granulosa cells was 
examined. 
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Materials and methods 
 
Chemicals 
Unless otherwise mentioned, all chemicals were purchased from Sigma-Aldrich (St. Louis, 
MO). 
 
Collection of OGCs 
Collection, in vitro growth culture, and in vitro maturation of OGCs were carried out as 
described previously (Hirao et al., 2004; Makita and Miyano, 2014) with some modifications. Briefly, 
bovine ovaries were collected at a local slaughter house and conveyed to the laboratory. The ovaries 
were washed once with 0.2% (w/v) cetyltrimethylammonium bromide (Wako Pure Chemical 
Industries, Osaka, Japan) and then three times with Dulbecco’s PBS containing 0.1% (w/v) polyvinyl 
alcohol (PBS-PVA). A surgical blade (No. 10; Feather Safety Razor, Tokyo, Japan) and forceps were 
used to make the ovarian cortical slices. Early antral follicles (1.2–1.8 mm in diameter) were collected 
from ovarian cortical slices in 25 mM HEPES-buffered medium 199 (HEPES-199; Nissui 
Pharmaceutical, Tokyo, Japan) containing 0.1% (w/v) PVA, 0.85 mg/mL sodium bicarbonate (Wako 
Pure Chemical Industries), and 0.08 mg/mL kanamycin sulfate. The follicles were opened using a 
blade (No. 10) and forceps to collect OGCs. The diameter of oocytes (excluding the zona pellucida) 
was measured by an ocular micrometer attached to an inverted microscope. OGCs with oocyte 
diameters of 105–115 µm were selected. Some of the OGCs were used for in vitro growth culture, 
and the remainder were used as an in vivo control (growing oocytes: GO). OGCs from middle antral 
follicles (4–6 mm in diameter) were sucked up with follicular fluid using a syringe and needles (18 
ga; Terumo, Tokyo, Japan), and then the diameter of oocytes was measured. The OGCs collected from 
middle antral follicles with oocytes of 120–130 µm in diameter served as an in vivo fully grown control 
(fully grown oocytes: FO). 
 
In vitro growth culture of OGCs 
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Collected bovine OGCs from early antral follicles were cultured for 5 days in 96-well culture 
plates (BioCoat™ Collagen I Cellware; Becton Dickinson Biosciences, Bedford, MA) containing 200 
µL culture medium. Each OGC was placed in a well of a 96-well plate for individual culture. The 
culture conditions were 5% CO2, 5% O2, and 90% N2 in humidified air at 38.5°C. The basic culture 
medium was Minimum Essential Medium Alpha (GIBCO, Invitrogen, Scotland, UK) supplemented 
with 4% (w/v) polyvinylpyrrolidone (molecular weight 360,000), 5% (v/v) fetal bovine serum (ICN 
Biomedicals, Aurora, OH), 4 mM hypoxanthine, 50 µg/mL ascorbic acid 2-glucoside (Hayashibara 
Biochemical Laboratories, Okayama, Japan), 55 µg/mL cysteine, 0.05 mM dexamethasone, 100 
ng/mL 17β-estradiol, 10 ng/mL androstenedione, 1 mM sodium pyruvate, 2.2 mg/mL sodium 
bicarbonate, and 0.08 mg/mL kanamycin sulfate (Makita and Miyano, 2014). The culture medium 
was also separately supplemented with different PDE inhibitors: 0, 2.5, 5, 50, or 100 µM of IBMX; 
0, 5, 25, or 50 µM of rolipram; 0, 2.5, 5, or 10 µM of cilostamide; and 0, 2.5, 5, or 25 µM of milrinone. 
These concentrations of PDE inhibitors were selected on the basis of the IC50 values of PDE inhibitors 
and previous reports (Mayes and Sirard, 2002; Sasseville et al., 2009a). The day of OGC collection 
was designated as Day 0, and half (100 µL) of the culture medium was replaced with new medium on 
Day 3. Antrum formation by OGCs was examined on Day 1, Day 3 and Day 5 by identifying visible 
spaces surrounded by granulosa cells. 
 After 5 days of growth culture, OGCs showing complete detachment of granulosa cells from 
the oocytes and/or oocytes with cytoplasmic degeneration were not used for further experiments. The 
diameter of oocytes from OGCs with a healthy structure was measured using an ocular micrometer. 
Some of the oocytes were denuded mechanically, fixed in aceto-ethanol and stained with 1% (w/v) 
aceto-orcein (Wako Pure Chemical Industries). The stages of meiotic division were examined by 
Nomarski interference microscopy. Other oocytes were used for further experiments (in vitro 
maturation and lucifer yellow dye transfer). The stained oocytes were classified on the basis of 
morphology of the chromatin and nuclear envelope (Motlík et al., 1978; Hirao et al., 1995; Makita 
and Miyano, 2014). Oocytes before meiotic resumption were at the filamentous chromatin (FC), 
stringy chromatin (SC), or germinal vesicle (GV) stage (I-IV). After resumption of meiosis, the stages 
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were classified into early diakinesis (ED), late diakinesis (LD), metaphase I (MI) and metaphase II 
(MII). Oocytes showing cytoplasmic or nuclear abnormalities were considered degenerated oocytes.  
 
In vitro maturation of oocytes 
The OGCs surviving after 5 days of in vitro growth culture were further used for in vitro 
maturation. OGCs were cultured in a 50 µL droplet of maturation medium under paraffin oil in an 
atmosphere of 5% CO2 in air at 38.5°C for 22 h. About 5 OGCs were cultured in each droplet. The 
maturation medium was bicarbonate-buffered medium 199 supplemented with 10% (v/v) fetal bovine 
serum, 0.1 mg/mL sodium pyruvate, 0.1 IU/mL human menopausal gonadotropin (Asuka, Tokyo, 
Japan), 2.2 mg/mL sodium bicarbonate and 0.08 mg/mL kanamycin sulfate. After 22 h, oocytes were 
denuded mechanically with the help of 0.1% (w/v) hyaluronidase and using a small-bore pipette. Then 
they were fixed in aceto-ethanol and stained with 1% (w/v) aceto-orcein to examine the stage of oocyte 
maturation. The oocytes showing female pronuclei or cytoplasmic degeneration were considered 
degenerated oocytes. OGCs collected from early antral follicles (1.2‒1.8 mm in diameter) and middle 
antral follicles (4‒6 mm in diameter) were also subjected to maturation, and served as in vivo grown 
control groups. 
 
Lucifer yellow (LY) dye transfer 
Healthy OGCs after 5 days of growth culture were further used for LY dye transfer. 
Microinjection of LY to OGCs was done as described by Isobe et al. (1998) with some modifications. 
Oocytes in OGCs were microinjected with HEPES-199 containing 10% (w/v) LY CH dilithium salt 
(fluorescent stain). Holding and injection pipettes were prepared by pulling glass capillary tubes with 
a pipette puller (P-97/IVF; Sutter Instrument, Novato, CA), followed by processing with a Microforge 
(MF-79; Narishige Scientific Instrument Lab., Tokyo, Japan). LY solution was injected into each 
oocyte by regulating the duration and gas pressure of injection using an electric controlled pneumatic 
microinjector (IM-30; Narishige Scientific Instrument Lab.). The volume of LY solution injected to 
the oocytes was estimated at approximately 4 pL based on the procedure of Isobe et al. (1998). After 
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microinjection, OGCs were placed in HEPES-199 to allow the spread of dye from oocytes to 
granulosa cells through gap junctions. The spread of LY from oocytes to the outermost layer of 
granulosa cells took 25–30 min, when the OGCs were observed under a fluorescence microscope 
(Olympus IX70 Multi-parameter Fluorescence Microscope; Olympus, Tokyo, Japan). Therefore, all 
of the OGCs were examined for dye transfer under a fluorescence microscope (FV1000-KDM; 
Olympus) after 30 min of LY microinjection. 
 The OGCs were classified into two categories depending on the spread of the dye to the 
granulosa cells. In dye-positive OGCs, approximately more than half of the granulosa cells 
surrounding the oocytes were stained with LY dye, and in dye-negative OGCs, approximately less 
than half of the granulosa cells surrounding the oocytes were stained with LY dye. As a negative 
control, freshly collected OGCs from 1.2‒1.8 mm follicles were incubated for 15 h with in vitro 
growth culture medium containing carbenoxolone disodium salt (30 µM), a gap junction blocker 
(Davidson et al., 1986; Webb et al., 2002). Then the oocytes were microinjected with LY. Some of 
the freshly collected OGCs from 1.2‒1.8 mm follicles were microinjected with LY just after collection 
as the positive control. 
 
Statistical analysis 
Mean diameters of oocytes were compared using a t-test: two-sample assuming unequal 
variances (Excel software). All data from other experiments were subjected to one-way ANOVA 
followed by Duncan’s multiple range test (IBM SPSS Statistics for Windows, Version 22.0. Armonk, 
NY: IBM Corp.). Values of P < 0.05 were considered significant. 
 
 
 
 
 
13 
 
Results 
Growth of oocytes 
The changes of oocyte diameter are shown in Figure 2. The diameter of oocytes increased 
significantly from Day 0 to Day 5 in media with or without PDE inhibitors. But there were no 
significant differences in the oocyte diameters after culture among the inhibitors. In all groups, the 
diameters of oocytes after culture increased similarly to those of oocytes grown in vivo (Fig. 2. “FO” 
in each group) in the middle antral follicles (4–6 mm). 
  
Antrum formation 
The typical morphologies of bovine OGCs during growth culture are shown in Figure 3. After 
placing OGCs in the culture media, granulosa cells began to proliferate and formed a multilayered 
structure surrounding the oocytes. After 2–3 days, some of the OGCs formed visible antra by 
developing spaces inside the multilayers of granulosa cells (Day 3). The antra became more prominent 
day by day until the end of culture (Day 5).  
IBMX induced a significantly higher percentage of antrum formation by OGCs than in the 
OGCs without IBMX (Figs. 3A and 4A). Among the IBMX groups, there was no significant 
difference in antrum formation. Rolipram had no significant effect on antrum formation (Figs. 3B and 
4B). However, the cultures with cilostamide induced significantly higher percentages of antrum 
formation compared to those without the inhibitor (Figs. 3C and 4C). Among the cilostamide groups, 
the maximum percentage of antrum formation (88%) was observed at the concentration of 5 µM. 
Milrinone also induced antrum formation during the growth culture of oocytes. Milrinone 5 µM 
ensured the maximum percentage of antrum formation by OGCs (87%), which was significantly 
higher than that of the OGCs cultured without milrinone (Figs. 3D and 4D). 
 
Effect of PDE inhibitors on meiotic arrest of oocytes during in vitro growth 
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Figure 2  Effect of PDE inhibitors (A: IBMX; B: rolipram; C: cilostamide; and D: milrinone) on the 
growth of bovine oocytes. In each graph (A–D), the white box labeled by GO (left) represents the 
diameter of oocytes isolated from early antral follicles (1.2–1.8 mm) and the white box labeled FO 
(right) represents the diameter of oocytes isolated from middle antral follicles (4–6 mm). The numbers 
of oocytes (n) used for each experiment are shown at the bottom of each box. The mean diameters of 
oocytes are shown at the top of each box. In each graph, boxes with the same pattern (except the white 
boxes) indicate the whisker plot of oocyte diameters before (Day 0) and after (Day 5) growth culture. 
The numbers below each graph represent the concentration (µM) of PDE inhibitors used for growth 
culture. Boxes with different letters (a, b) are significantly different (t-test; P < 0.05). 
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Figure 3  Typical morphologies of bovine OGCs during in vitro growth culture. OGCs were cultured 
for 5 days with IBMX (A), rolipram (B), cilostamide (C), and milrinone (D) at different 
concentrations. OGCs growth-cultured without PDE inhibitor are labeled “None”. In each set of 
pictures (A–D), the top, middle and bottom panels represent Day 1, 3 and 5 of culture, respectively, 
and the different concentrations (µM) of PDE inhibitors are shown in increasing order from left to 
right. The scale bar represents 200 µm.   
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Figure 4  Antrum formation of bovine OGCs during in vitro growth culture with PDE inhibitors (A: 
IBMX; B: rolipram; C: cilostamide; and D: milrinone). Antrum formation was confirmed by 
examining spaces formed inside the granulosa cell layers on Day 1, Day 3 and Day 5 of the culture 
period. The numbers of OGCs (n) used for each experiment are shown in each graph. Different types 
of lines indicate different concentrations (µM) of the respective PDE inhibitor. Data are shown as 
average percentages from at least three replicated cultures. The letters “a–c” denote significantly 
different values (P < 0.05). 
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Bovine growing oocytes (GO; 105–115 µm) collected from early antral follicles (1.2–1.8 mm) 
were at the FC or SC stage, and only a few were at the GV (I-IV) stage (Table 1). On the other hand, 
in vivo fully grown oocytes (FO; 120–130 µm) collected from middle antral follicles (4–6 mm) were 
at the GV (I-IV) stage. 
A broad-spectrum PDE inhibitor, IBMX (50 µM), maintained the meiotic arrest of bovine 
growing oocytes over 5 days of growth culture (Fig. 5). A PDE4 inhibitor, rolipram, did not maintain 
the meiotic arrest of oocytes. Cilostamide, a PDE3 inhibitor, maintained the meiotic arrest of oocytes 
over 5 days. The percentages of GV-stage oocytes were 57%, 80%, 94%, and 84% in media containing 
0, 2.5, 5, and 10 µM cilostamide, respectively (Fig. 5). To ensure the effect of the PDE3 inhibitor, 
another PDE3 inhibitor, milrinone, was added to the culture. Milrinone also maintained the meiotic 
arrest of oocytes, and there was a significantly higher percentage (87%) of GV-stage oocytes when 5 
µM milrinone was used than without milrinone (Fig. 5). At the maximum concentrations of 
cilostamide (10 µM) and milrinone (25 µM), some oocytes were degenerated after growth culture (8% 
and 7% of the total number of oocytes, respectively), which was similar to the level of degeneration 
in 100 µM IBMX (Table 1). 
 
In vitro maturation of oocytes grown with PDE inhibitors 
Since the broad-spectrum PDE inhibitor (IBMX) and PDE3 inhibitors (cilostamide and 
milrinone) maintained meiotic arrest of oocytes during growth culture, but the PDE4 inhibitor did not, 
oocytes grown with IBMX and PDE3 inhibitors were further subjected to in vitro maturation to assess 
their maturation competence.   
Growing oocytes collected from early antral follicles resumed meiosis after in vitro 
maturation, but most of them remained at the ED or LD stage, and only a few oocytes matured to the 
MII stage (GO in Fig. 6 and Table 2). Fully grown oocytes collected from middle antral follicles 
resumed meiosis and most of them matured to MII (FO in Fig. 6 and Table 2). Oocytes grown with 
PDE inhibitors matured to MII at higher percentages than the oocytes without PDE inhibitors. IBMX  
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Table 1  Effect of PDE inhibitors on meiotic arrest of bovine growing oocytes during in vitro growth 
culture. 
PDE 
inhibitor 
Conc. 
(µM) 
No. of 
oocytes 
examined 
No. (%) of oocytes at the stage 
FC SC GV ED LD MI DG 
GO 39 21 (54) 17 (44) 1   (2) h 0 0 0 0 
IBMX 
0 33 0 0 19 (55) fg 7   (24) ab 4 (12) 2 (6) ab 1 (3) 
2.5 33 0 0 22 (67) cdefg 6   (18) abcd 3 (9) 1 (3) ab 1 (3) 
5 30 0 0 21 (68) cdefg 4   (14) bcd 4 (14) 1 (4) ab 0 
50 33 0 0 28 (85) abcd 2   (6) bcd 3 (9) 0 0 
100 35 0 0 27 (77) bcdef 3   (9) bcd 2 (5) 0 3 (9) 
FO 45 0 0 45 (100) a 0 0 0 0 
GO 30 20 (66) 8 (27) 2   (7) h 0 0 0 0 
Roli 
0 40 0 0 19 (48) fg 11 (27) ab 6 (14) 4 (11) a 0 
5 37 0 0 18 (46) g 12 (33) a 6 (19) 1 (2) ab 0 
25 38 0 0 25 (63) defg 9   (24) ab 3 (8) 1 (5) ab 0 
50 38 0 0 23 (57) efg 8   (23) abc 4 (13) 3 (7) ab 0 
FO 37 0 0 37 (100) a 0 0 0 0 
GO 33 19 (58) 13 (39) 1   (3) h 0 0 0 0 
Cilo 
0 36 0 0 21 (57) efg 7   (21) abcd 5 (15) 0 3 (7) 
2.5 36 0 0 29 (80) abcd 4   (11) bcd 2 (6) 1 (3) ab 0 
5 35 0 0 33 (94) ab 1   (3) d 1 (3) 0 0 
10 36 0 0 30 (84) abcd 3   (8) bcd 0 0 3 (8) 
FO 30 0 0 30 (100) a 0 0 0 0 
GO 38 26 (68) 10 (27) 2   (5) h 0 0 0 0 
Milr 
0 29 0 0 18 (62) defg 5   (17) abcd 3 (11) 0 3 (10) 
2.5 30 0 0 24 (79) abcde 0 3 (11) 1 (3) ab 2 (7) 
5 31 0 0 27 (87) abc 1   (3) cd 3 (10) 0 0 
25 29 0 0 24 (83) abcd 1   (3) cd 2 (7) 0 2 (7) 
FO 30 0 0 30 (100) a 0 0 0 0 
 
FC: Filamentous chromatin stage, SC: Stringy chromatin stage, GV: Germinal vesicle stage (I-IV), 
ED: Early diakinesis, LD: Late diakinesis, MI: Metaphase I, and DG: Degenerated. In each PDE 
inhibitor section, the meiotic stages of oocytes before growth culture are shown as “GO” and in vivo 
fully grown oocytes are shown as “FO”. Data are shown in total number (%) of oocytes from at least 
three replicated cultures. Values with different superscripts (a–h) are significantly different within the 
same meiotic stage (P < 0.05). Conc.: concentration. Roli: rolipram. Cilo: cilostamide. Milr: 
milrinone. 
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Figure 5  Effect of PDE inhibitors on the meiotic arrest of bovine growing oocytes during growth 
culture. The percentages of oocytes at the germinal vesicle (GV I-IV) stage after 5 days of in vitro 
growth culture are shown in the bar graphs. White bar graphs represent oocytes without PDE inhibitors 
and bars with the same pattern represent the same PDE inhibitor at different concentrations. The 
concentrations (µM) of PDE inhibitors are given below the bar graphs. Data are shown as the means 
± SEM from at least three replicated cultures. Bars with different letters (a–g) are significantly 
different (P < 0.05). 
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Figure 6  Maturation ability of bovine oocytes grown with PDE inhibitors. The average percentages 
of oocytes that matured to MII are shown in the bar graphs. In each panel, the white bar labeled GO 
(left) represents the mean percentage of oocytes collected form early antral follicles (1.2–1.8 mm) that 
matured to MII. The white bar labeled FO (right) represents the mean percentage of oocytes collected 
from middle antral follicles (4–6 mm) that matured to MII. Oocytes grown without PDE inhibitor are 
shown with gray bars. Bars with the same pattern represent the same PDE inhibitor at different 
concentrations. Concentrations (µM) of PDE inhibitors are given below the bar graphs. Data are 
shown as the means ± SEM from at least three replicated cultures. Bars with different letters (a–e) are 
significantly different (P < 0.05). 
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Table 2  Meiotic competence of bovine oocytes grown with PDE inhibitors. 
PDE 
inhibitor 
Conc. 
(µM) 
No. of 
oocytes 
examined 
No. (%) of oocytes at the stage 
GV ED LD MI MII DG 
GO 46 1 (2) 27 (60) 
a 12 (24) ab 0 3   (7) e 3   (7) bcde 
IBMX 
0 38 0 4   (10) b 3   (8) bc 3 (8) ab 20 (53) d 8   (21) abc 
2.5 38 0 2   (5) b 3   (8) bc 1 (3) b 22 (58) bcd 10 (26) a 
5 38 0 3   (8) b 3   (8) bc 1 (3) b 26 (68) abcd 5   (13) abcde 
50 37 0 3   (8) b 2   (5) bc 1 (3) b 29 (79) abc 2   (5) bcde 
100 37 0 2   (5) b 3   (8) bc 1 (3) b 24 (65) abcd 7   (19) abcd 
FO 18 0 1   (6) 
b 1   (6) bc 1 (6) ab 15 (82) ab 0 
GO 33 0 19 (58) a 12 (36) a 1 (3) b 1   (3) e 0 
Cilo 
0 32 0 4   (13) b 3   (9) bc 6 (19) a 15 (47) d 4   (12) abcde 
2.5 31 0 2   (6) b 3   (10) bc 3 (10) ab 18 (58) bcd 5   (16) abcde  
5 31 0 1   (3) b 0 3 (10) ab 24 (77) abc 3   (10) abcde  
10 31 0 3   (10) b 3   (10) bc 2 (6) ab 17 (55) cd 6   (19) abc  
FO  36 0 2   (6) 
b 2   (6) bc 2 (6) ab 29 (80) abc 1   (2) de  
GO 27 0 19 (70) a 5   (18) bc 1 (4) ab 1   (4) e 1   (4) cde  
Milr 
0 28 0 4   (14) b 2   (7) bc 2 (7) ab 14 (50) d 6   (22) ab 
2.5 29 0 2   (7) b 3   (10) bc 2 (7) ab 18 (62) abcd 4   (14) abcde 
5 29 0 2   (7) b 1   (4) bc 0 23 (79) abc 3   (10) abcde  
25 30 0 3   (10) b 2   (7) bc 0 18 (60) abcd 7   (23) ab  
FO 33 0 3   (9) b 1   (3) c 1 (3) b 28 (85) a 0 
 
GV: Germinal vesicle stage (I-IV), ED: Early diakinesis, LD: Late diakinesis, MI: Metaphase I, MII: 
Metaphase II, and DG: Degenerated. In each PDE inhibitor section, the maturation competence of 
growing oocytes before growth culture are shown as “GO” and in vivo fully grown oocytes are shown 
as “FO”. Data are shown in total number (%) of oocytes from at least three replicated cultures. Values 
with different superscripts (a–e) are significantly different within the same meiotic stage (P < 0.05). 
Conc.: concentration. Cilo: cilostamide. Milr: milrinone. 
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at 50 µM, cilostamide at 5 µM and milrinone at 5 µM showed similar percentages of MII oocytes after 
in vitro maturation, which were comparable to the percentages of fully grown oocytes in vivo. 
 
Effect of PDE inhibitors on gap junctional communication between oocytes and granulosa cells 
Gap junctional communication between oocytes and granulosa cells was examined in OGCs 
cultured with each type of PDE inhibitor. For each PDE inhibitor, the most effective concentration for 
the meiotic arrest of oocytes was selected. Typical diffusion patterns of LY from oocytes to granulosa 
cells are shown in Figure 7. As expected, in the OGCs before in vitro growth culture, gap junctional 
communication between oocytes and granulosa cells was observed as 100% dye-positive (GO in Fig. 
8). IBMX (50 µM) and cilostamide (5 µM) maintained the communications (dye-positive OGCs) at 
significantly higher percentages (81% and 84%, respectively) than the culture with 25 µM rolipram 
and without PDE inhibitor (55% and 46%, respectively). In the negative control group with 
carbenoxolone (30 µM), only 25% of OGCs were dye-positive. 
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Figure 7  Representative images of LY dye transfer from bovine oocytes to granulosa cells. LY 
solution was microinjected into each oocyte and allowed to spread from oocytes to granulosa cells for 
30 min. The OGCs showing spread of LY from the oocyte to approximately more than half of the 
granulosa cells were designated as dye-positive (A). The OGCs showing spread of LY approximately 
less than half of the granulosa cells are designated as dye-negative (B); their appearance was similar 
to the negative control OGCs (C) treated with carbenoxolone (30 µM) for 15 h before LY 
microinjection. The scale bar represents 40 µm. 
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Figure 8  Effect of PDE inhibitors on the maintenance of gap junctional communication between 
bovine oocytes and granulosa cells. LY was microinjected into the oocytes (GO) before in vitro 
growth culture as the positive control, and in vitro grown oocytes (none, IBMX 50 µM, rolipram 25 
µM, and cilostamide 5 µM) at the end of the culture (Day 5). The transfer of LY from oocytes to 
surrounding granulosa cells was examined and the OGCs were classified as dye-positive or 
dye-negative. Carbenoxolone was used as a gap junction blocker. Oocytes before growth culture were 
incubated with carbenoxolone (30 µM) for 15 h then microinjected with LY and served as the negative 
control. The numbers of oocytes (n) used for each experiment are shown inside the respective bars. 
Data are shown as the means ± SEM from at least three replicated cultures. Bars with different letters 
(a–d) are significantly different (P < 0.05). 
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Discussion 
 
In the ovary, oocytes and granulosa cells coordinately develop within the follicles and 
bidirectional communication is maintained between oocytes and granulosa cells. The oocyte 
development includes increase in diameter and acquisition of complete meiotic competence. 
Granulosa cell development involves changes in shape, proliferation, formation of an antrum structure 
and differentiation to cumulus and mural granulosa cells. In the present study, bovine OGCs 
containing partially meiotic-competent growing oocytes collected from early antral follicles were used 
for the in vitro growth culture. In the culture with specific PDE inhibitors, the oocytes continued their 
growth and acquired complete meiotic competence, while at the same time the granulosa cells 
proliferated to form antrum structures, and the gap junctional communication was maintained between 
oocytes and granulosa cells.    
The meiotic arrest of partially meiotic-competent bovine oocytes was maintained by IBMX 
and PDE3 inhibitors (cilostamide and milrinone) during growth culture. On the other hand, PDE4 
inhibitor was unable to maintain the meiotic arrest of growing oocytes. The basic growth culture 
medium used in this study contained hypoxanthine, which is a naturally occurring PDE inhibitor 
present in follicular fluid (Downs et al., 1985). Hypoxanthine maintained the meiotic arrest of growing 
oocytes collected from 11‒12 day old mice in the growth culture for 12 days (Eppig and Downs, 
1987). Bovine oocyte-granulosa cell complexes containing incompetent growing oocytes (90‒99 µm) 
also maintained meiotic arrest in the growth culture for 11‒14 days in hypoxanthine-supplemented 
media (Harada et al., 1997; Makita and Miyano, 2014). However, partially meiotic-competent bovine 
oocytes resumed meiosis in the basic growth culture medium in the present study. Meiotic resumption 
of bovine fully grown oocytes has been shown to be prevented by PDE3-specific inhibitors during in 
vitro maturation culture (Mayes and Sirard, 2002; Thomas et al., 2002). The results of the present 
study using bovine growing oocytes are consistent with these reports, and suggest that meiotic arrest 
of partially meiotic-competent bovine oocytes can be attained in the same manner as that of fully 
grown oocytes. Since the functional PDE3 is not present in bovine cumulus granulosa cells but is 
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present in oocytes (Thomas et al., 2002) and PDE3 activity is undetectable in isolated PDE3A 
knockout mice oocytes (Masciarelli et al., 2004), it is thought that PDE3 inhibitors predominantly 
inhibited PDE3A in partially meiotic-competent bovine oocytes to maintain their meiotic arrest. 
The LY dye transfer experiment revealed that bovine growing oocytes from 1.2‒1.8 mm 
follicles had gap junctional communication with surrounding granulosa cells. Because oocytes of this 
size are still in the growing stage, they must take nutrients and metabolites from granulosa cells in 
order to complete their growth. After 5 days of growth culture, IBMX and a PDE3 inhibitor 
(cilostamide) maintained the gap junctional communication between oocytes and granulosa cells, 
whereas a PDE4 inhibitor (rolipram) did not maintain the gap junctional communication. Studies with 
rodent (Dekel et al., 1981; Salustri and Siracusa, 1983; Bornslaeger and Schultz, 1985; Sherizly et al., 
1988), porcine (Motlik et al., 1986; Sasseville et al., 2009b; Dieci et al., 2013; Santiquet et al., 2013) 
and bovine (Šutovský et al., 1993; Luciano et al., 2004; Atef et al., 2005; Albuz et al., 2010; Sugimura 
et al., 2014) oocytes suggest that gap junctional communication decreases with the meiotic resumption 
of oocytes. In bovine oocytes, gap junctional communication between oocytes and cumulus cells 
disappears after 6 h of in vitro maturation culture (Šutovský et al., 1993). In the present study, it is 
thought that the PDE3 inhibition prevented meiotic resumption of bovine growing oocytes during 
growth culture, which in turn prevented the disconnection of gap junctional communication between 
oocytes and granulosa cells. 
The increase in the diameters of oocytes after growth culture was similar between oocytes 
cultured with or without PDE inhibitors. When bovine oocyte-granulosa cell complexes collected 
from early antral follicles (0.4−0.7 mm) were cultured, steroid hormones (17β-estradiol and 
androstenedione) promoted oocyte growth and connection through transzonal projections with 
granulosa cells (Makita and Miyano, 2014). Although oocyte-granulosa cell complexes cultured 
without steroid hormones did not maintain the transzonal projections, the oocytes increased in 
diameter after 14 days of growth culture. In the present study, the oocytes appeared to continue 
growing after being placed in the growth culture, although the gap junctional communication with the 
granulosa cells was reduced at the end of growth culture. 
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When OGCs were cultured with IBMX or PDE3 inhibitors, oocytes acquired higher 
maturation competence than those cultured without any inhibitor. This indicates that the oocytes 
whose meiotic resumption was arrested by the inhibitors gained maturational competence. Bovine 
growing oocytes <110 µm in diameter have been shown to engage in RNA synthesis at a 3-fold greater 
rate than fully grown oocytes of ≥120 µm in diameter (Fair et al., 1995). RNA synthesis in the oocytes 
continues after antrum formation in cows (Crozet et al., 1986) and pigs (Motlik et al., 1984) until the 
oocytes reach full size. A recent study indicated that RNA synthesis of bovine growing oocytes is 
regulated by gap junctional communication between oocytes and cumulus cells through a cAMP-
mediated mechanism (Luciano et al., 2011). In that study, when gap junctional communication was 
experimentally interrupted by 1-heptanol, oocyte RNA synthesis suddenly ceased, and cilostamide, a 
PDE3 inhibitor, prevented the effect of 1-heptanol. Moreover, the authors reported that 24 h-culture 
of bovine growing oocytes with cilostamide before in vitro maturation enhanced the ability of oocytes 
to mature and undergo early embryonic development (Luciano et al., 2011). It has also been shown 
that short-term pre-maturation culture of fully grown oocytes with IBMX and dbcAMP increased the 
ability of oocytes to mature and contribute to embryo production in cows (Huang et al., 2013) and 
pigs (Funahashi et al., 1997). Considering that gap junctional communication regulates oocyte RNA 
synthesis through a cAMP-mediated mechanism (Luciano et al., 2011), and that IBMX and PDE3 
inhibitors maintained the gap junctional communication between oocytes and granulosa cells for the 
5 day culture period in the present study, it appears that the inhibitors supported the RNA synthesis 
of bovine growing oocytes for their growth and acquisition of full meiotic competence to MII. 
After 5 days of growth culture, there was a significant increase in antrum formation by the 
OGCs cultured with IBMX and PDE3 inhibitors, whereas the antrum formation was not promoted by 
the PDE4 inhibitor. This result indicates that inhibition of PDE3, which is functional specifically in 
oocytes (Thomas et al., 2002), promotes antrum formation by surrounding granulosa cells. Several 
factors have been identified that regulate follicular antrum formation (Rodgers and Irving-Rodgers, 
2010). Shen et al. (1998) reported that porcine granulosa cells cultured with oocytes formed an antrum 
structure, although they did not form an antrum structure in the absence of oocytes. Among the oocyte-
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secreted factors, growth differentiation factor-9 (GDF 9) (Dong et al., 1996; Elvin et al., 1999) and 
bone morphogenetic protein-15 (BMP15) (Yan et al., 2001) have been shown to be essential for 
granulosa cell proliferation in mice. Although it is not known whether these oocyte-derived factors 
act on antrum formation, it is interesting to speculate that inhibition of oocyte PDE3 promotes the 
production of some oocyte-derived antrum formation factors. Further study will be needed to reveal 
the relationship between oocyte PDE3 and follicular antrum formation. 
In summary, inhibition of PDE3 was shown to maintain the meiotic arrest of bovine growing 
oocytes and to sustain their gap junctional communication with granulosa cells for 5 days of growth 
culture, thereby contributing to the acquisition of full maturation competence of the oocytes. 
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CHAPTER III 
Effect of PDE inhibitors on expression of oocyte-derived factors 
 
Introduction 
 
 The results in Chapter II showed that PDE3 inhibitors maintained meiotic arrest of bovine 
growing oocytes and gap junctional communication between oocytes and granulosa cells, thereby 
promoted maturational competence of the oocytes. Moreover, PDE3 inhibitors promoted antrum 
formation by OGCs. However, how the PDE3 inhibitors contribute to antrum formation was not clear. 
As PDE3 inhibitors are thought to specifically work in the oocytes, these inhibitors possibly promote 
expression of some oocyte-derived factors that affect surrounding granulosa cells. The objectives of 
this chapter is to examine the effect of PDE inhibitors on expression of oocyte-derived factors. 
  PDE family members degrade cyclic adenosine monophosphate (cAMP) in the ovarian 
follicles (Conti et al., 2002). PDE3 degrades oocyte cAMP, thus the content of oocyte cAMP 
decreases. PDE3 family-specific inhibitors (e.g. cilostamide, milrinone and Org 9935) have been 
shown to block the resumption of meiosis efficiently in mouse (Shitsukawa et al., 2001), rat (Tsafriri 
et al., 1996), cattle (Mayes and Sirard, 2002; Thomas et al., 2002), human (Nogueira et al., 2003) and 
pig (Laforest et al., 2005; Grupen et al., 2006) oocytes. PDE3A-null female mice are infertile 
(Masciarelli et al., 2004). Interestingly, they ovulate fully grown oocytes, which fail to resume 
meiosis. The inhibition of PDE3 also prolongs gap junctional communication between oocytes and 
cumulus cells which is mediated by cAMP (Luciano et al., 2011). However, the effect of PDE3 
inhibitors on oocyte-derived factors is unknown.    
 GDF9 and BMP15 are two important growth factors secreted from mammalian oocytes. 
GDF9 and BMP15 are members of TGF-β superfamily. This superfamily is composed of more than 
35 proteins including members of the TGF-β, activin/inhibin, anti-Müllerian hormone, GDF and BMP  
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subfamilies, and share common structural motifs (Chang et al., 2002). GDF9 (McGrath et al., 1995) 
and BMP15 (Dube et al., 1998; Laitinen et al., 1998) were first identified as growth factors. Later 
these growth factors have been shown to be expressed only in oocytes in several mammalian species 
(Erickson and Shimasaki, 2000). GDF9 and BMP15 work on granulosa cells by paracrine actions 
(Elvin et al., 1999). Follicle development beyond the primary stage does not occur in GDF9 null mice 
(Dong et al., 1996). Homozygous mutations in the GDF9 gene (Hanrahan et al., 2004) and active 
immunization against GDF9 (Juengel et al., 2002) in sheep also block folliculogenesis at primary 
stage. Although the roles of these oocyte-derived factors are suggested in folliculogenesis, it has not 
been known what regulates the expression of GDF9 and BMP15 in oocytes. In Chapter III, it is aimed 
to examine whether PDE inhibitors induce expression of these oocyte-derived factors in cultured 
oocytes.   
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Materials and methods 
 
Chemicals 
 All chemicals were purchased from Sigma-Aldrich unless otherwise stated. 
 
Collection and in vitro culture of OGCs 
 The collection methods of OGCs from bovine ovaries were described in Chapter II. OGCs 
containing growing oocytes (105–115 µm in diameter) collected from bovine early antral follicles 
(1.2–1.8 mm) were cultured for 5 days. The culture methods and basic culture medium were described 
in Chapter II. OGCs were cultured in the medium with rolipram (25 µM) and cilostamide (5 µM) 
under an atmosphere of 5% CO2, 5% O2 and 90% N2 in humidified air at 38.5°C. The concentrations 
of those PDE inhibitors were selected based on the results of Chapter II. 
 
RNA extraction and reverse transcription PCR (RT-PCR) 
Bovine OGCs were used to prepare denuded oocytes and granulosa cell complexes (GCs). At 
least 30 OGCs, 30 denuded oocytes and GCs separated from 30 denuded oocytes using a small-bore 
pipette were used for RNA extraction. Total RNAs were extracted using an RNeasy Plus Micro Kit 
(Qiagen, Austin, TX) according to the manufacturer’s instructions, and eluted with 14 µL of RNase-
free water. Reverse transcription was performed using ReverTra® Ace qPCR RT Master Mix 
(Toyobo, Tsuruga, Japan) according to the manufacturer’s instructions in a final volume of 20 µL. 
The RT-PCR reactions were carried out in a 25 µL reaction volume using PCR Master Mix (Promega 
Corporation, Madison, WI) according to the manufacturer’s instructions. Cycling conditions for the 
amplifications were 95°C for 2 min; followed by 30 cycles of 95°C for 30 sec, 65°C for 1 min, and 
72°C for 1 min; followed by 72°C for 5 min with a final hold at 12°C. The primers were designed 
according to known sequences in GenBank (accession numbers: bovine β-ACTIN, NM_173979.3; 
GDF9, NM_174681.2; and BMP15, NM_001031752.1). The primers were purchased from Thermo 
Fisher Scientific (Waltham, MA). The primer sequences and their expected PCR product sizes are 
shown in Table 3.  
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Table 3  Primer sequences used for bovine β-ACTIN, GDF9 and BMP15 genes and their expected 
sizes of RT-PCR products. 
Gene Primer Nucleotide sequence Expected size (bp) 
β-ACTIN 
β-ACTIN -F 5́ -AAGATCAAGATCATCGCGCCC- 3́ 
350 
β-ACTIN -R 5́ -CTTTGGGAATGCTCGATCCAACC- 3 ́
GDF9 
GDF9 -F 5́ -CCATGGCGCTTCCCAACAAAT- 3́ 
416 
GDF9 -R 5́ -CACTGATGGAAGGGTTCCTGCT- 3́ 
BMP15 
BMP15 -F 5́ -TCTCAGAGGCTCCTGGCACAT- 3́ 
489 
BMP15 -R 5́ -TGACGAGCCCTCCTCAAGAGA- 3 ́
 
F: forward primer and R: reverse primer. Both forward and reverse primer sequences for all  
genes of interest are given in the 5́ -to-3́ -direction.  
 
 
Table 4  Primer sequences used for bovine β-ACTIN, GDF9 and BMP15 genes for qPCR. 
Gene Primer Nucleotide sequence 
β-ACTIN 
β-ACTIN -F 5́ -GCAAGCAGGAGTACGATGAGT- 3 ́
β-ACTIN -R 5́ -GGGTGTAACGCAGCTAACAGT- 3́ 
GDF9 
GDF9 -F 5́ -AACACTGTTCGGCTCTTCACC- 3 ́
GDF9 -R 5́ -ACTGATGGAAGGGTTCCTGCTG- 3́ 
BMP15 
BMP15 -F 5́ -CTCAGAGGCTCCTGGCACAT- 3 ́
BMP15 -R 5́ -TGATGGCGGTAAACCACAGT- 3́ 
 
F: forward primer and R: reverse primer. Both forward and reverse primer  
sequences for all genes of interest are given in the 5́ -to-3́ -direction.  
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RT-PCR products were electrophoresed and visualized in 1% (w/v) agarose gel containing 
ethidium bromide. From the agarose gel, RT-PCR products were purified using a QIAquick gel 
extraction kit (Qiagen). Sequencing of gel-purified products was performed using a BigDye 
Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems, Foster City, CA) and an ABI 3130 
Genetic Analyzer (Applied Biosystems). The results confirmed that the nucleotide sequences of the 
RT-PCR products were identical to the bovine cDNA sequences of β-ACTIN, GDF9, and BMP15. 
 
Quantitative real-time PCR (qPCR) 
 Oocytes (at least 15) were collected from OGCs cultured with rolipram and cilosatmide for 5 
days, and denuded for extraction of total RNA and reverse transcription as described above. 
Quantitative analysis of gene expression was performed in a 10 µL reaction volume using a 
THUNDERBIRD qPCR Mix (Toyobo) and a CFX96 Real-Time PCR Detection System (Bio-Rad 
Laboratories, Hercules, CA) according to manufacturer’s protocols. Reaction conditions were as 
follows: 95°C for 2 min; followed by 40 cycles of 95°C for 2 sec, 55°C for 5 sec, and 65°C for 5 sec; 
followed by a melting curve program. The results were recorded by the Bio-Rad CFX Manager 
Software version 3.0. In each experiment, levels of GDF9 and BMP15 mRNAs were normalized to 
the β-ACTIN (an internal control) mRNA levels. The relative levels of GDF9 and BMP15 mRNAs 
after culture are shown compared to in vivo growing oocytes (control group). The primers were 
designed according to known sequences in GenBank as described above and purchased from Thermo 
Fisher Scientific. The primers used for the analysis are listed in Table 4.  
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Results and discussion 
 
Expression of GDF9 and BMP15 mRNAs in bovine oocytes and granulosa cells 
The expression levels of GDF9 and BMP15 mRNAs in bovine oocytes and GCs were 
examined by RT-PCR (Fig. 9). Bovine β-ACTIN was used as an internal control. OGCs and oocytes 
(Oo) showed bands of PCR products for the GDF9 and BMP15 mRNAs at the expected size, whereas 
GCs did not show any band. The oocyte-specific expression of these mRNAs has been reported 
previously in several mammalian species, including mice (Elvin et al., 2000), cattle (Bodensteiner et 
al., 1999), sheep (Bodensteiner et al., 1999) and humans (Aaltonen et al., 1999). The results of the 
present study are consistent with these reports and suggest that GDF9 and BMP15 mRNAs are 
expressed specifically in oocytes but not in GCs. 
 
Effect of PDE inhibitors on expression of GDF9 and BMP15 mRNAs 
The relative expression levels of GDF9 and BMP15 mRNAs in bovine oocytes after culture 
with rolipram and cilostamide were examined by qPCR (Fig. 10). Bovine β-ACTIN was used as an 
internal control. Growing oocytes (105–115 µm in diameter) collected from early antral follicles (1.2–
1.8 mm) was used as the control to calculate relative fold changes in expression of GDF9 and BMP15 
mRNAs after culture with PDE3 and PDE4 inhibitors. The levels of GDF9 and BMP15 mRNAs 
decreased in oocytes after culture with rolipram which is similar to those of oocytes cultured without 
PDE inhibitor, whereas the relative mRNA levels of GDF9 and BMP15 increased in the oocytes after 
culture with cilostamide.  
Since PDE3 specifically functions in bovine oocytes (Thomas et al., 2002) and PDE3 inhibitor 
increased expression of GDF9 and BMP15 mRNAs in the present study, it is reasonable to conclude 
that PDF3 inhibitor increased expression of those oocyte-derived factor mRNAs after culture. On the 
other hand, PDE4 is compartmentalized in granulosa cells (Thomas et al., 2002). In the present study, 
it is thought that PDE4 inhibitor affected on granulosa cells which did not increase the expression of 
GDF9 and BMP15 mRNAs in oocytes.  
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Figure 9  Expression of GDF9 and BMP15 mRNAs in bovine oocytes and granulosa cells. Bovine 
oocytes (Oo), granulosa cell complexes (GCs) and oocyte-granulosa cell complexes (OGCs) were 
used for extraction of total RNA. The cDNA was synthesized using total RNA as a template for RT-
PCR. The RT-PCR product bands using primer sets specific to bovine β-ACTIN, GDF9 and BMP15 
are shown in the top, middle and bottom panels, respectively. Bovine β-ACTIN was used as an internal 
control. The right lane represents the molecular mass marker. The expected sizes of the PCR products 
for β-ACTIN, GDF9 and BMP15 were 350 bp, 416 bp and 489 bp, respectively. 
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Figure 10  Relative expression levels of GDF9 and BMP15 mRNAs in oocytes after 5 days of culture 
with rolipram and cilostamide were assessed by qPCR. Oocytes cultured without PDE inhibitor were 
marked as “None”. Rolipram (25 µM) was used as a PDE4 inhibitor and cilostamide (5 µM) as a 
PDE3 inhibitor. Bovine β-ACTIN was used as internal control. Data are presented as fold changes 
relative to control group (growing oocytes; GO) and are shown as the mean ± SEM from at least three 
replications. *P < 0.05; **P < 0.01. 
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In conclusion, inhibition of PDE3 in the oocytes increases the expression of oocyte-derived 
factors (GDF9 and BMP15) after 5 days of culture, whereas inhibition of PDE4 does not increase the 
expression of these factors.   
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CHAPTER IV 
Effect of GDF9 and BMP15 on antrum formation by bovine granulosa cells 
 
Introduction 
 
In mammalian ovaries, a small population of primordial follicles enters the growth phase and 
develops through the primary and secondary follicle stages. Follicular granulosa cells proliferate to 
develop a multilayered structure during the progression of follicular development. Later, a fluid-filled 
cavity called an antrum is formed inside the follicles as they reach the antral follicle stage. In antral 
follicles, granulosa cells separate to form cumulus granulosa cells which enclose the oocytes, and 
mural granulosa cells which form the inner layer of the follicle wall (Wigglesworth et al., 2015). 
 Bidirectional communication between oocytes and granulosa cells is required for ovarian 
function and fertility (Eppig, 1991). Granulosa cells supply nutrients, metabolites and molecular 
signals to the oocytes, while oocytes promote the proliferation, differentiation and function of 
granulosa cells. The oocytes play a crucial role in the regulation of follicular development (Matzuk et 
al., 2002). Oocytes are required for initial primordial follicle formation (Soyal et al., 2000) and 
regulate the specific characteristics and functions between cumulus granulosa cells and mural 
granulosa cells in mice (Diaz et al., 2007). During oocyte maturation, oocytes secrete a cumulus 
expansion-enabling factor to induce cumulus expansion (Buccione et al., 1990b; Sugiura et al., 2010). 
In addition, it has been suggested that oocytes promote contact between granulosa cells and induce 
antrum formation in pigs (Shen et al., 1998). 
GDF9 and BMP15 are two important oocyte-derived factors that regulate ovarian functions 
(Elvin et al., 2000; Emori and Sugiura, 2014). In GDF9 null mice, folliculogenesis does not progress 
beyond the primary follicle stage, and defective granulosa cell proliferation is observed in the follicles 
(Dong et al., 1996). BMP15 null mice exhibit subfertility (Yan et al., 2001), and ewes carrying 
BMP15 mutations are infertile, and exhibit arrest of follicular development at the primordial stage 
(Hanrahan et al., 2004). 
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(Hanrahan et al., 2004). Immunization against GDF9 and BMP15 has been shown to reduce the 
follicular development and ovulation rate in cattle (Juengel et al., 2009). Under various culture 
conditions, GDF9 and BMP15 promote granulosa cell proliferation and function in mice (Mottershead 
et al., 2012), humans (Mottershead et al., 2015), cattle (McNatty et al., 2005) and sheep (McNatty et 
al., 2005). Although it has been suggested that both GDF9 and BMP15 are important in follicular 
development, their role in follicular antrum formation has not been elucidated. 
Many approaches have been considered to grow mammalian oocytes in vitro, and it has been 
reported that cultured follicles and OGCs develop antrum structures (Eppig et al., 1996). Some studies 
have reported the development of antrum structures in mice (Nayudu and Osborn, 1992), humans 
(Roy and Treacy, 1993) and pigs (Hirao et al., 1994) by in vitro culture of the preantral follicles. Other 
studies have shown that rat (Gore-Langton and Daniel, 1990) and bovine (Harada et al., 1997) OGCs 
form antrum structures in culture. Hirao et al. (2004) developed a growth culture system in which 
bovine OGCs containing oocytes of <100 µm in diameter were cultured in medium supplemented 
with a high concentration of polyvinylpyrrolidone for 14 days. This system effectively supported the 
growth of bovine small oocytes, and OGCs formed antrum structures during the culture. In Chapter 
II, PDE3 inhibitors promoted the formation of antrum structures by bovine OGCs, and in Chapter III, 
PDE3 inhibitor increased expression of GDF9 and BMP15 mRNAs in the oocytes. Considering these 
results, it is thought that the increased GDF9 and BMP15 possibly affect on granulosa cells to promote 
the formation of antrum structures. However, it is not yet known whether these oocyte-derived factors 
induce the formation of antrum structures in vitro. 
In this Chapter, bovine OGCs were collected from early antral follicles (1.2–1.8 mm in 
diameter) and used to prepare oocytectomized complexes (OXCs) and GCs. All of these three types 
of complexes were cultured for 5 days. The OGCs formed antrum structures, whereas OXCs and GCs 
did not form the structure. Next, the effects of GDF9 and BMP15 on the formation of antrum structures 
by these complexes were examined. The exogenous GDF9 and BMP15 induced the formation of 
antrum structures by OXCs and GCs.  
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Materials and methods 
 
Chemicals 
All chemicals were purchased from Sigma-Aldrich unless otherwise indicated. GDF9 
(Recombinant Mouse GDF-9; 739-G9) and BMP15 (Recombinant Human BMP-15; 5096-BM) were 
purchased from R&D Systems (Minneapolis, MN). 
 
Collection of OGCs 
OGCs were collected from early antral follicles (1.2–1.8 mm in diameter) in bovine ovaries 
as described in Chapter II. 
  
Preparation of complexes 
OGCs were used to prepare two types of complexes: OXCs and GCs. OXCs were prepared 
by removing the oocyte cytoplasm with the germinal vesicle from the OGCs using a microinjection 
apparatus (Narishige Scientific Instrument Lab.) attached to an inverted microscope (Olympus IX70 
Multi-parameter Fluorescence Microscope; Olympus). Holding pipettes were prepared by pulling 
glass capillary tubes with a pipette puller (P-97/IVF; Sutter Instrument), followed by processing with 
a Microforge (MF-79; Narishige Scientific Instrument Lab.). Injection pipettes (MIC-CUST-30) were 
purchased from Origio Humagen (Charlottesville, VA). The injection pipettes had an inner diameter 
of 11 µm at the needle tip. The oocyte cytoplasm along with the germinal vesicle was suctioned by 
the negative pressure of the injection pipette after insertion into the oocyte. The resulting OXCs 
contained a zona pellucida and granulosa cells. The GCs were prepared by removing whole oocytes 
with the zona pellucida from OGCs using a small-bore pipette. 
 
In vitro culture of complexes 
The collected complexes (OGCs, OXCs and GCs) were cultured for 5 days in 96-well culture 
plates (BioCoat™ Collagen I Cellware; Becton Dickinson Biosciences) containing 200 µL of culture 
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medium as described in Chapter II. The culture medium was further supplemented with 100 ng/mL 
of GDF9, 10 ng/mL of BMP15, or a combination of 100 ng/mL of GDF9 and 10 ng/mL of BMP15. 
The combination of GDF9 and BMP15 was used because the heterodimers of these oocyte-derived 
factors are 10–3000 fold more bioactive than the homodimers (Peng et al., 2013). The concentrations 
of GDF9 and BMP15 were selected on the basis of their ED50 values and previous reports (McNatty 
et al., 2005; Sudiman et al., 2014). The day of complex preparation was considered Day 0, and half 
(100 µL) of the culture medium was replaced with new medium at Day 3. The formation of antrum 
structures by complexes was examined at Day 1, Day 3 and Day 5 by identifying visible spaces 
surrounded by granulosa cells. Complexes showing cytoplasmic degeneration of oocytes (in OGCs), 
detachment of granulosa cells from the zona pellucida (in OGCs and OXCs), or loss of the aggregated 
structure of granulosa cells (in all complexes) were classified as disintegrated complexes; all others 
were considered complexes maintaining their integrity. 
 
Hematoxylin and eosin staining of complexes 
The complexes were subjected to hematoxylin and eosin Y staining. The media were carefully 
removed from the 96-well plates after 5 days of culture, and the complexes were washed three times 
with PBS-PVA and fixed in 4% (w/v) paraformaldehyde (Wako Pure Chemical Industries) for 30 min. 
The complexes were then washed three more times with PBS-PVA. Mayer’s hematoxylin solution 
(Wako Pure Chemical Industries) was used to stain the complexes for 10 min, then washed out with 
tap water for 10 min. Finally, the complexes were stained with 1% (w/v) eosin Y (Wako Pure 
Chemical Industries) for 2 min, and the eosin Y was washed out with tap water for 1 min. A glycerol-
water mixture (1:4) was used to mount the complexes. 
    
Preparation of histological sections 
To prepare the histological sections, the complexes were cultured on Millicell® inserts 
(Merck Millipore, Billerica, MA) placed in petri dishes (Falcon No. 351008, Becton Dickinson 
Biosciences) according to the method described previously (Makita et al., 2016), with some 
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modifications. After 5 days of culture, the complexes were washed three times with PBS-PVA and 
fixed in 4% (w/v) paraformaldehyde for 2 h. Ovarian follicles 1.2–1.8 mm in diameter were fixed for 
3 h as controls. The complexes and follicles were washed three times with PBS-PVA and dehydrated 
by a series of increasing concentrations of ethanol (50% for 30 min, followed by 70%, 80%, 90%, 
100% and 100% for 20 min each). The complexes that maintained integrity were detached from the 
Millicell® inserts before the final dehydration by 100% ethanol. They were infiltrated and embedded 
in JB-4 resin (Polysciences, Niles, IL). A rotary microtome (HM 335 E; MICROM International 
GmbH, Walldorf, Germany) was used to make 7–8 µm sections from the specimens. Mayer’s 
hematoxylin and eosin Y were used to stain the sections as described above.  
 
Statistical analysis 
All data were subjected to one-way ANOVA followed by Tukey’s HSD (IBM SPSS Statistics 
for Windows). Values of P < 0.05 were considered statistically significant. 
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Results 
 
Effect of GDF9 and BMP15 on the integrity of complexes 
The typical morphologies of complexes during culture are shown in Figure 11. In each 
complex, there were several layers of granulosa cells when they were initially placed in culture 
medium regardless of the presence of the oocyte or zona pellucida. During the culture, granulosa cells 
of OGCs adjacent to the culture plate were attached to it, and then proliferated to form multilayered 
rigid structures in some complexes (Fig. 11A). In other complexes, attached granulosa cells 
proliferated outward from the original complex. The combination of GDF9 and BMP15 promoted the 
development of the multilayered structure of OGCs (Fig. 11A). In OXCs and GCs, the initial 
aggregates composed of multilayered granulosa cells (Day 1 in Figs. 11B and 11C) lost their structure 
completely by Day 5 without supplementation of GDF9 and BMP15 (Day 5 in Figs. 11B and 11C). 
GDF9 or BMP15 alone maintained the multilayered structure in OXCs, but not in GCs. However, the 
combination of GDF9 and BMP15 promoted the development of a multilayered structure in both 
OXCs (Fig. 11B) and GCs (Fig. 11C). During culture, some of the OGCs in all groups, and some of 
the OXCs and GCs cultured with GDF9 and/or BMP15 formed visible antrum structures by 
developing spaces inside the multilayered granulosa cells (Fig. 11, Day 3). These antrum structures 
became more prominent by the end of culture (Fig. 11, Day 5). However, no antrum structures were 
formed in OXCs (Fig. 11B) or GCs (Fig. 11C) without supplementation of GDF9 and BMP15. 
The integrity of complexes is summarized in Figure 12. In the presence of oocytes, 65% of 
OGCs maintained their integrity at Day 5 (Fig. 12A). Neither GDF9 nor BMP15 significantly 
increased the integrity of OGCs when administered singly, but the combination of GDF9 and BMP15 
increased the integrity of OGCs. The integrity of OXCs and GCs, both of which lacked oocytes, 
decreased markedly at Day 5 (Figs. 12B and 12C). However, either GDF9 or BMP15 alone maintained 
the integrity of OXCs, while the two in combination increased OXC integrity more than either growth 
factor administered singly (Fig. 12B). In GCs, neither GDF9 nor BMP15 alone increased integrity, 
but the combination of both increased the integrity significantly (Fig. 12C). 
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Figure 11  Typical morphologies of complexes during culture. Bovine oocyte-granulosa cell 
complexes (OGCs; A), oocytectomized complexes (OXCs; B) and granulosa cell complexes (GCs; 
C) were cultured for 5 days with GDF9 (100 ng/mL), BMP15 (10 ng/mL) or a combination of GDF9 
(100 ng/mL) and BMP15 (10 ng/mL). Complexes cultured without GDF9 or BMP15 are represented 
as “None”. The top, middle and bottom panels in each set of pictures (A, B and C) represent Day 1, 3 
and 5 of culture, respectively. The scale bar represents 200 µm.  
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Figure 12  Integrity of complexes (A: OGCs; B: OXCs and C: GCs) during in vitro culture with GDF9 and BMP15. Complexes showed degenerative signs, 
such as cytoplasmic degeneration of oocytes, detachment of granulosa cells from zona pellucida, or loss of the aggregated structure of granulosa cells were 
classified as disintegrated complexes. The numbers of complexes (n) used in each group are shown in each graph (A, B and C). Different types of lines indicate 
GDF9 (100 ng/mL) and BMP15 (10 ng/mL) either alone or a combination of GDF9 (100 ng/mL) and BMP15 (10 ng/mL). Data are shown as average 
percentages from at least three replicated cultures. The letters “a–c” denote significantly different values (P < 0.05).  
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Effect of GDF9 and BMP15 on the formation of antrum structures by complexes 
The formation of antrum structures by the complexes is shown in Figures 13 and 14. OGCs 
developed antrum structures after culture without supplementation of GDF9 and BMP15 (Fig. 13A), 
whereas OXCs and GCs did not form antrum structures without the growth factors (Figs. 13B and 13C). 
GDF9 and BMP15 alone induced formation of antrum structures in OXCs and GCs, but the combination 
of GDF9 and BMP15 achieved even more potent promotion of the development of antrum structures in 
all types of complexes (Fig. 13). 
 Representative histological images of antrum structures in the complexes are shown in Figure 
14. The in vivo grown follicles (1.2–1.8 mm) used as a control contained a large antrum (Fig. 14A). 
Cultured OGCs formed multiple spaces (antrum structures) between the oocytes and the peripheries of 
the complex (Fig. 14B). Upon completion of culture, OXCs contained the zona pellucida surrounded 
by granulosa cells, although no antrum structures were formed inside the complexes (Fig. 14C). 
Similarly, GCs did not develop any antrum structures without growth factors (Fig. 14D). However, 
GDF9 and BMP15 induced OXCs (Fig. 14E) and GCs (Fig. 14F) to form multiple antrum structures 
inside the complexes, which were similar to those in the OGCs grown without growth factors (Fig. 
14B). 
 
Effect of GDF9 and BMP15 on granulosa cell morphology 
OGCs, OXCs and GCs were stained with hematoxylin and eosin after culture for 5 days to 
examine the morphology of granulosa cells. Because the masses of granulosa cells in the original 
complexes were heavily stained, the shape of individual granulosa cells was not observed. However, 
granulosa cells outgrowing from the complexes showed distinctive shapes according to the type of 
complex and/or treatment. Granulosa cells adjacent to the OGC were pebble-like in shape (Fig. 15A), 
whereas cells more distant from the original complex exhibited spreading into fibroblast-like shapes 
with a large nucleus and flat cytoplasm (Fig. 15B). Between these two types of cells there was another 
type of cells with a rhomboid shape and long cellular projections (Fig. 15C). Outgrowing granulosa 
cells
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Figure 13  Formation of antrum structures by complexes (A: OGCs; B: OXCs and C: GCs) during in vitro culture with GDF9 and BMP15. Formation of 
antrum structures was confirmed by examining spaces formed inside the granulosa cell layers on Day 1, Day 3 and Day 5 of the culture period. The numbers 
of complexes (n) used in each group are shown in each graph (A, B and C). Different types of lines indicate GDF9 (100 ng/mL) and BMP15 (10 ng/mL) either 
alone or a combination of GDF9 (100 ng/mL) and BMP15 (10 ng/mL). Data are shown as average percentages from at least three replicated cultures. The 
letters “a–d” denote significantly different values (P < 0.05). 
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Figure 14  Representative images of histological sections of complexes (B: OGCs; C and E: OXCs; 
and D and F: GCs) after 5 days of culture. There is an antrum inside the in vivo grown bovine early 
antral follicle (1.2–1.8 mm in diameter) (A). OGCs developed antrum structures in vitro (B). OXCs (C) 
and GCs (D) did not develop antrum structure in vitro. However, OXCs (E) and GCs (F) developed 
antrum structures, when they were cultured with GDF9 and BMP15. The scale bar represents 100 µm. 
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Figure 15  A representative image of distinctive shapes of outgrowing granulosa cells from OGCs 
cultured with GDF9. Outgrowing granulosa cells exhibited pebble-like shape (A), fibroblast-like shape 
(B) or rhomboid shape with long cell projections (C). The scale bar represents 100 µm.  
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cells from OGCs showed these three types of cells without growth factors (Fig. 16A).  In the absence 
of oocytes and exogenous growth factors in OXCs and GCs, granulosa cells exhibited only fibroblast-
like shape and spread extensively from the complexes (Figs. 16B and 16C). OXCs and GCs cultured 
with GDF9 showed both fibroblast-like and rhomboid-shaped cells, although the complexes cultured 
with BMP15 alone showed only fibroblast-like cells. However, in the presence of GDF9 and BMP15, 
fibroblast-like cells were reduced, while rhomboid-shaped and pebble-like cells were observed in all 
types of complexes. 
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Figure 16  Typical morphologies of outgrowing granulosa cells from complexes (A: OGCs; B: OXCs 
and C: GCs) after 5 days of culture. The complexes were cultured with GDF9 (100 ng/mL), BMP15 
(10 ng/mL) or a combination of GDF9 (100 ng/mL) and BMP15 (10 ng/mL). Complexes cultured 
without GDF9 or BMP15 are represented as “None”. The scale bars represent 200 µm. 
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Discussion 
  
The mechanisms regulating follicular antrum formation have received scant attention (Gosden 
et al., 1988; Rodgers and Irving-Rodgers, 2010) and the role of oocytes in particular has not been 
sufficiently elucidated. One study has suggested that oocytes are required for antrum formation in pigs 
(Shen et al., 1998). In that study, oocyte-cumulus-mural granulosa cell complexes from pig early antral 
follicles formed antrum structures when they were cultured in collagen gels for 8 days. When the 
oocytes surrounded by cumulus cells in the complexes were replaced by denuded oocytes (O/G 
complexes) or Sephadex G-25 beads (B/G complexes), the O/G complexes formed antrum structures, 
whereas the B/G complexes did not. Hirao et al. (2004) developed a culture system for growing OGCs 
collected from bovine early antral follicles (0.4–0.7 mm) with 4% polyvinylpyrrolidone for 14 days, 
and the complexes developed antrum structures in this system. In Chapter II using similar culture 
conditions, the inhibition of PDE3 that has been reported as oocyte-specific (Thomas et al., 2002), 
promoted the formation of antrum structures by bovine OGCs, which further indicated the engagement 
of oocytes in the process of antrum formation. 
GDF9 and BMP15 have been shown to regulate several follicular events (Juengel and McNatty, 
2005). GDF9-deficient female mice form primordial and primary follicles, but they exhibit a block in 
follicular development beyond the primary follicle stage, leading to infertility (Dong et al., 1996). 
Buccione et al. (1990b) found that the oocytes were required for cumulus expansion during oocyte 
maturation through the secretion of a putative cumulus expansion-enabling factor. Later, oocyte-derived 
GDF9 and BMP15 were identified as the cumulus expansion-enabling factors in mice (Yan et al., 2001; 
Su et al., 2004). It has been shown here that bovine growing oocytes participate in the formation of 
antrum structures, and that GDF9 and BMP15 are able to substitute for this oocyte role. Antrum 
structures were formed in OGCs due to the presence of oocytes while GDF9 and BMP15 also promoted 
the formation of antrum structures in OGCs. Moreover, OXCs and GCs, both of which lack oocytes, 
did not form antrum structures, but GDF9- and BMP15-induced formation of antrum structures was 
observed in these complexes. These results provide clear evidence that oocyte-derived factors are 
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required for the formation of antrum structures in bovine OGCs, and suggest that oocytes participate in 
follicular antrum formation via GDF9 and BMP15.  
The OGCs used in this study contained oocytes and surrounding cumulus granulosa cells. I 
cannot rule out the possibility that the complexes are the mixture of cumulus granulosa cells and some 
mural granulosa cells. The complexes might also contain undifferentiated granulosa cells. The ability 
of mural granulosa cells to form an antrum structure has been examined in the pig (Shen et al., 1998). 
In the experiment, mural granulosa cells formed an antrum structure in the presence of denuded oocytes 
(Shen et al., 1998).  The role of oocytes in the proliferation of (i) undifferentiated granulosa cells from 
preantral follicles and (ii) more differentiated mural granulosa cells and cumulus granulosa cells from 
antral follicles was studied in mice (Vanderhyden et al., 1992). Oocyte-secreted factors promoted 
proliferation of undifferentiated granulosa cells and differentiated mural granulosa cells, but did not 
promote the proliferation of terminally differentiated cumulus cells (Vanderhyden et al., 1992). These 
observations indicated that oocyte-secreted factors act on granulosa cells only at specific stages of their 
differentiation (Vanderhyden et al., 1992). In the present study, GDF9 and BMP15 might act on 
undifferentiated granulosa cells or mural granulosa cells in the complexes to make a multilayered 
structures and promote the formation of antrum structures. 
Outgrowing granulosa cells from bovine OGCs appeared fibroblast-like, rhomboid and pebble-
like in culture. Granulosa cells from OXCs and GCs cultured without growth factors or with BMP15 
alone showed only a fibroblast-like shape. Cultured rat granulosa cells contiguous to oocytes maintained 
their granulosa-like appearance, while those farthest away from oocytes showed a fibroblast-like shape 
(Nekola and Nalbandov, 1971). Further, granulosa cells cultured without oocytes differentiated into a 
fibroblast-like shape (Nekola and Nalbandov, 1971). In the present study, the bovine granulosa cells 
were thought to differentiate into fibroblast-like cells without oocytes. When OXCs and GCs were 
cultured with GDF9, the granulosa cells appeared fibroblast-like and rhomboid-shaped. The culture of 
these complexes with GDF9 and BMP15 reduced the fibroblast-like cells, similar to the OGCs cultured 
without GDF9 and BMP15. Moreover, the rhomboid cells were connected to each other by long, thin 
cytoplasmic projections resembling filopodia. A previous morphodynamics study of oocyte-follicle cell 
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association during the development of human ovarian follicles revealed rhomboid-shape cumulus cells 
with microvilli and cilia in the antral follicles (Motta et al., 1994). A recent study indicated that GDF9 
from mouse growing oocytes induced granulosa cells to generate specialized filopodia, which 
penetrated the zona pellucida and provided a foundation for oocyte-granulosa cell communication (El-
Hayek et al., 2018). Together with these reports, present result suggest that GDF9 might promote the 
generation of filopodia in outgrowing granulosa cells, which changing the morphology of granulosa 
cells to a rhomboid shape. OXCs and GCs did not maintain complex integrity during the 5-day culture, 
although addition of GDF9 and BMP15 maintained the integrity of these complexes. The connection 
between granulosa cells whose growth was induced by GDF9 and BMP15 seems to contribute to the 
maintenance of complex integrity. 
In summary, the results show that GDF9 and BMP15 are required for formation of antrum 
structures by bovine granulosa cells, thereby suggesting that oocytes participate in follicular antrum 
formation through these oocyte-derived factors.   
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CHAPTER V 
General summary 
 
Bovine ovaries contain a huge number of oocytes. A small population of oocytes enter the 
growth phase, complete their growth, mature and are ovulated. During the growth period, oocytes 
increase in diameter from 30 µm to 125 µm, and acquire the competence to resume meiosis and to 
mature to metaphase II (MII). Non-growing oocytes (30 µm) are surrounded by a single layer of flat-
shaped pre-granulosa cells. When oocytes start to grow, surrounding pre-granulosa cells become cubic 
granulosa cells to form primary follicles. The granulosa cells proliferate and form multilayered structure 
in secondary follicles. Later an antrum structure is formed and the granulosa cells differentiate to 
cumulus granulosa cells and mural granulosa cells in antral follicles. Coincident with the formation of 
antrum structure, oocytes acquire the competence to resume meiosis, although they maintained meiotic 
arrest until luteinizing hormone stimulation.  
Many approaches have been taken to grow bovine small growing oocytes (<100 µm) in vitro. 
On the other hand, less emphasis has been given to the growth culture of >100 µm growing oocytes. 
Oocytes of these size are able to resume meiosis, although they are incompetent to mature to MII. Thus 
these oocytes are considered “partially meiotic-competent”, and their precocious resumption of meiosis 
during growth culture makes it difficult for them to grow to full meiotic competent oocytes. The 
maintenance of meiotic arrest depends on oocyte cAMP in several mammals. Inhibition of cAMP- 
degrading enzymes, phosphodiesterases (PDEs), might prevent meiotic resumption of bovine growing 
oocytes. During in vitro growth culture of oocytes, oocyte-granulosa cell complexes (OGCs) develop 
antrum structures. The mechanism underlying antrum formation in the ovary has not been established, 
although participation of oocytes is suggested in culture of pig oocyte-cumulus-mural granulosa cell 
complexes. The aim of this study is to examine the effect of different kinds of PDE inhibitors on the 
growth and meiotic arrest of bovine partially meiotic-competent oocytes in vitro and elucidate the role 
of oocytes in the formation of antrum structures by cultured OGCs. 
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In Chapter II, the effect of PDE inhibitors on the growth and meiotic arrest of bovine partially 
meiotic-competent oocytes was examined. OGCs with oocyte diameters of 105–115 µm were collected 
from early antral follicles (1.2–1.8 mm in diameter) and cultured for 5 days with IBMX (broad-spectrum 
PDE inhibitor), rolipram (PDE4 inhibitor), and cilostamide and milrinone (PDE3 inhibitors). The 
concentration of different PDE inhibitors were 0, 2.5, 5, 50, or 100 µM of IBMX; 0, 5, 25, or 50 µM of 
rolipram; 0, 2.5, 5, or 10 µM of cilostamide; and 0, 2.5, 5, 25 µM of milrinone. The mean diameter of 
oocytes in all PDE inhibitor groups increased to an average 120–124 µm after culture which were 
similar to those oocytes collected from middle antral follicles (4–6 mm in diameter). IBMX, cilostamide 
and milrinone maintained meiotic arrest of oocytes and gap junctional communication between oocytes 
and granulosa cells. Moreover, these inhibitors promoted the formation of antrum structures by OGCs. 
On the other hand, rolipram did not maintain meiotic arrest of oocytes and gap junctional 
communication between oocytes and granulosa cells. Rolipram did not increase the percentages of 
OGCs that formed antrum structures. In subsequent in vitro maturation, oocytes grown with IBMX, 
cilostamide or milrinone showed full maturation competence. These results indicate that inhibition of 
PDE3 maintain meiotic arrest of oocyte and gap junctional communication between oocytes and 
granulosa cells thereby contributing to their acquisition of full maturation competence. Since the 
formation of antrum structures was promoted in OGCs cultured with PDE3 inhibitors, which has been 
reported functional only in oocytes, it is suggested that the PDE3 inhibitors might promote expression 
of some oocytes-derived factors that induce the formation of antrum structures by OGCs. 
 
Oocyte-derived members of transforming growth factor β (TGF-β) superfamily, growth 
differentiation factor-9 (GDF9) and bone morphogenetic protein-15 (BMP15) regulate several follicular 
events in mammals. In Chapter III, the effect of PDE inhibitors on the expression of these oocyte-
derived factors was examined. First, their oocyte-specific expression was confirmed by RT-PCR. OGCs 
collected from early antral follicles (1.2–1.8 mm) were cultured for 5 days in the medium with 25 µM 
rolipram or 5 µM cilostamide. The relative expression of these oocytes-derived factors after culture 
with PDE inhibitors were assessed by qPCR. Cilostamide significantly increased the expression of 
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GDF9 and BMP15 mRNAs, whereas rolipram did not increase the expression of these oocyte-derived 
factors. These results indicate that inhibition of PDE3 induces expression of GDF9 and BMP15 in the 
oocytes, and suggest that the increased GDF9 and BMP15 possibly affect on granulosa cells to promote 
the formation of antrum structures. 
 
In Chapter IV, the effects of exogenous GDF9 and BMP15 on antrum formation by bovine 
granulosa cells were examined. OGCs containing growing oocytes (105‒115 µm) were collected from 
early antral follicles (1.2‒1.8 mm) and used to prepare oocytectomized complexes (OXCs) and 
granulosa cell complexes (GCs). The complexes were cultured for 5 days with or without GDF9 (100 
ng/mL) and BMP15 (10 ng/mL) either alone or in combination. The OGCs maintained their complex 
integrity and developed antrum structures, whereas OXCs and GCs neither maintained the integrity nor 
developed any antrum structure without growth factors. GDF9 or BMP15 alone increased the integrity 
of these complexes and induced antrum structures in OXCs and GCs. Moreover, the combination of 
GDF9 and BMP15 was more potent for both phenomena in all types of complexes. In OXCs and GCs 
cultured without GDF9 and BMP15 or with BMP15 alone, outgrowing granulosa cells differentiated 
into fibroblast-like cells. The combination of GDF9 and BMP15 suppressed the appearance of 
fibroblast-like cells in OXCs and GCs during the culture. Instead, the granulosa cells appeared 
rhomboid and pebble-like in shape which were similar to those in OGCs cultured without 
supplementation of GDF9 and BMP15. These results suggest that oocytes maintain complex integrity 
by preventing granulosa cell differentiation and participate in follicular antrum formation via GDF9 and 
BMP15. 
 
In summary, these results suggest that inhibition of PDE3 supports oocyte growth and meiotic 
arrest, and gap junctional communication between oocytes and granulosa cells in cultured bovine OGCs 
containing partially meiotic-competent oocytes. Inhibition of PDE3 also increases expression of GDF9 
and BMP15 mRNAs in the oocytes, and GDF9 and BMP15 maintain complex integrity by preventing 
granulosa cell differentiation and induce antrum formation. In the ovary, maintenance of meiotic arrest 
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of oocytes and gap junctional communication between oocytes and granulosa cells is required during 
the growth of partially meiotic-competent oocytes for acquisition of full meiotic competence. It is 
thought that some inhibitory mechanism of PDE3 in the oocytes leads meiotic arrest of oocytes and 
expression of oocyte-derived factors, GDF9 and BMP15. GDF9 and BMP15 regulate differentiation of 
granulosa cells to induce antrum formation. Thus oocytes maintain their meiotic arrest and grow to be 
fully meiotic competent oocytes, at the same time, they participate in antrum formation via GDF9 and 
BMP15. 
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